Sage Journals: Discover world-class research

Retricted access

Review article

First published 2023-10

Deucravacitinib: A Novel TYK2 Inhibitor for the Treatment of Moderate-to-Severe Psoriasis

Paige Kingston, Andrew Blauvelt, Bruce Strober [...]

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Review article

First published 2024-4

Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis

Thu Minh Truong, Gaurav N. Pathak, Amit Singal [...]

Annals of Pharmacotherapy

Retricted access

Letter

First published 2025

Oral JAK and TYK2 Inhibitors in the Management of Nail Psoriasis: An Evidence-Based Review

Jihad Abou Ali Waked, Siddhartha Sood, Abdul Aziz Abdul Ghafoor [...]

Journal of Cutaneous Medicine and Surgery

Retricted access

Research article

First published 2023-1

Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway

Wei Jing Loo, Irina Turchin, Vimal H. Prajapati [...]

Journal of Cutaneous Medicine and Surgery

Open access

Case report

First published 2023

Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report

Sarah Oliel, Sarah Moussa, Monica Stanciu [...]

Sage Open Medical Case Reports

Retricted access

Letter

First published 2025

Off-Label Use of Deucravacitinib in Dermatology: A Systematic Review

Kimia Ameri, Kim H. Tran, Jeffrey Toy [...]

Journal of Cutaneous Medicine and Surgery

Free access

Research article

First published 2021-6

Reducing False Positives through the Application of Fluorescence Lifetime Technology: A Comparative Study Using TYK2 Kinase as a Model System

Luke A. Greenhough, Gabriella Clarke, Alexander N. Phillipou [...]

Journal of Biomolecular Screening

Open access

Research article

First published 2024

Efficacy and safety of small molecule oral medications for psoriatic arthritis: a network meta-analysis of randomized controlled trials

Ya-Chu Tsai, Chen-Yiu Hung, Tsen-Fang Tsai

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2024-05

Deucravacitinib and shikonin combination therapy ameliorates imiquimod-induced psoriasis in mice

Ling Xu, Ying Jiang, Fuping Xu [...]

International Journal of Immunopathology and Pharmacology

Free access

Research article

First published 2004-1

Novel Shift of Jak/Stat Signalling Characterizes the Protective Effect of Aurintricarboxylic Acid (ATA) from Tumor Necrosis Factor-α Toxicity in Human B Lymphocytes

M. Marchisio, P. M. Grimley, A. Di Baldassarre [...]

International Journal of Immunopathology and Pharmacology

Search results